We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

16 hedge funds and large institutions have $835K invested in NRX Pharmaceuticals Warrant in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more funds holding

Funds holding: 13 → 16 (+3)

11% more capital invested

Capital invested by funds: $753K → $835K (+$82K)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VAS
VR Advisory Services
Cayman Islands
+$53K
2
RCM
Rivernorth Capital Management
Florida
+$41.2K
3
PC
Periscope Capital
Ontario, Canada
+$23.1K
4
CI
Cowen Inc
New York
+$7.54K
5
UBS Group
UBS Group
Switzerland
+$366

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$7.8K
2
BI
Bulldog Investors
New Jersey
-$1.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$339K – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$76K – – –
VAS
3
VR Advisory Services
Cayman Islands
$61K +$53K +115,772 +260%
WCMNY
4
Westchester Capital Management (New York)
New York
$46K – – –
BI
5
Bulldog Investors
New Jersey
$45K -$1.34K -2,919 -2%
OAM
6
Oxford Asset Management
United Kingdom
$40K – – –
AA
7
AQR Arbitrage
Connecticut
$38K – – –
PC
8
Periscope Capital
Ontario, Canada
$38K +$23.1K +50,400 +100%
KPF
9
K2 Principal Fund
Ontario, Canada
$35K – – –
RCM
10
Rivernorth Capital Management
Florida
$34K +$41.2K +90,041 New
6CM
11
683 Capital Management
New York
$31K – – –
YCM
12
Yakira Capital Management
Connecticut
$31K – – –
GCL
13
Glazer Capital LLC
New York
$17K -$7.8K -17,044 -26%
BCM
14
Basso Capital Management
Connecticut
$4K – – –
CI
15
Cowen Inc
New York
$6 +$7.54K +16,476 New
UBS Group
16
UBS Group
Switzerland
– +$366 +800 New

NRXPW Hedge Fund Activity: Q2 2018 in Review

16 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q2 2018, worth a combined $835K — up 11% from $753K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NRXPW positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was VR Advisory Services, adding an estimated $53K. The largest seller was Glazer Capital LLC, cutting an estimated $7.8K.

  • 16 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q2 2018, up from 13 in Q1 2018.
  • Funds reported $835K of NRX Pharmaceuticals Warrant stock for Q2 2018, up 11% quarter-over-quarter.
  • 3 funds opened new NRX Pharmaceuticals Warrant positions in Q2 2018 and 0 closed out, a net change of +3 holders.
  • The largest NRX Pharmaceuticals Warrant buyer in Q2 2018 was VR Advisory Services, an estimated $53K added.
  • The largest NRX Pharmaceuticals Warrant seller in Q2 2018 was Glazer Capital LLC, an estimated $7.8K sold.

Based on aggregated 13F filings for Q2 2018.